Phthalocyanines as medicinal photosensitizers: Developments in the last five years

X Li, BD Zheng, XH Peng, SZ Li, JW Ying… - Coordination Chemistry …, 2019 - Elsevier
Owing to their high extinction coefficients, long absorption wavelengths, and modification
tunable photophysical and photochemical properties, phthalocyanines (Pcs) have been …

Biological characteristics and clinical significance of soluble PD-1/PD-L1 and exosomal PD-L1 in cancer

M Niu, Y Liu, M Yi, D Jiao, K Wu - Frontiers in Immunology, 2022 - frontiersin.org
The immune checkpoint pathway consisting of the cell membrane-bound molecule
programmed death protein 1 (PD-1) and its ligand PD-L1 has been found to mediate …

Discovery of BLU-945, a reversible, potent, and wild-type-sparing next-generation EGFR mutant inhibitor for treatment-resistant non-small-cell lung cancer

MS Eno, JD Brubaker, JE Campbell… - Journal of medicinal …, 2022 - ACS Publications
While epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have
changed the treatment landscape for EGFR mutant (L858R and ex19del)-driven non-small …

The secret ally: immunostimulation by anticancer drugs

L Galluzzi, L Senovilla, L Zitvogel… - Nature reviews Drug …, 2012 - nature.com
It has recently become clear that the tumour microenvironment, and in particular the immune
system, has a crucial role in modulating tumour progression and response to therapy …

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

S Wilhelm, C Carter, M Lynch, T Lowinger… - Nature reviews Drug …, 2006 - nature.com
Since the molecular revolution of the 1980s, knowledge of the aetiology of cancer has
increased considerably, which has led to the discovery and development of targeted …

Recent advances on quinazoline derivatives: A potential bioactive scaffold in medicinal chemistry

R Karan, P Agarwal, M Sinha, N Mahato - ChemEngineering, 2021 - mdpi.com
This paper intended to explore and discover recent therapeutic agents in the area of
medicinal chemistry for the treatment of various diseases. Heterocyclic compounds …

Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies

M Hojjat-Farsangi - International journal of molecular sciences, 2014 - mdpi.com
Chemotherapeutic and cytotoxic drugs are widely used in the treatment of cancer. In spite of
the improvements in the life quality of patients, their effectiveness is compromised by several …

[HTML][HTML] Quinoxaline: A comprehension of current pharmacological advancement in medicinal chemistry

SK Suthar, NS Chundawat, GP Singh… - European Journal of …, 2022 - Elsevier
Quinoxaline is a fused heterocycle ring template present in diverse pharmacophore and
widely used in medicinal chemistry. Owing to its vast pharmaceutical profile, several …

Acceptorless Dehydrogenative Coupling of o-Aminobenzamides with the Activation of Methanol as a C1 Source for the Construction of Quinazolinones

F Li, L Lu, P Liu - Organic letters, 2016 - ACS Publications
A strategy for the synthesis of quinazolinones via acceptorless coupling of o-
aminobenzamides with methanol has been accomplished in the presence of the metal …

Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

B Sever, MD Altıntop, MO Radwan, A Özdemir… - European journal of …, 2019 - Elsevier
Epidermal growth factor receptor (EGFR, also known as HER1) and HER2, prominent
members of receptor tyrosine kinase (RTK) superfamily, have been reported as diagnostic or …